Definium Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $302.2M
Liabilities Breakdown FY2024
Total Liabilities: $60.7M
Asset Breakdown
Total Assets: $302.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $273.7M | 90.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $19.9M | 6.6% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $8.5M | 2.8% |
Liabilities Breakdown
Total Liabilities: $60.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.0M | 3.3% |
| Long-Term Debt | $21.9M | 36.0% |
| Other Liabilities | $36.8M | 60.7% |